Viloxazine's once-daily extended-release formula has been approved to treat ADHD in children ages 6 to 17.

In patients between the age of 6 to 11, the suggested dose is 100 mg PO daily. If needed, this dosage can be increased by 100 mg weekly until a maximum dose of 400 mg is reached.

In patients between the ages of 12 to 17, the suggested dose is 200 mg PO daily. This dose can be increased after a week to 200 mg daily for a maximum dose of 400 mg.

In patients with severe kidney disease (eGFR <30 ml/min/1.73 m^2), dosing should begin at 100 mg daily and can be increased by 50 to 100 mg until reaching a maximum dose of 200 mg.